🕵️ Medtronic PLC ($MDT)
SEC insider & ownership activity, last 12 months · CIK 1613103 · every row links its SEC filing
Over the last 12 months insiders sold $8.8M with no open-market buying against it. Kiil Harry Skip sold $5.5M (Feb–Jun). 1 planned sale is pending, the largest $139K (Kiil Harry Skip). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $8.8M (15 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kiil Harry Skip | 0 | – | 7 | $5.5M | Jun 8, 2026 |
| Gregory L. Smith | 0 | – | 7 | $3.1M | Nov 19, 2025 |
| Matthew R. Walter | 0 | – | 1 | $258K | Jul 8, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.5% | 13G | Apr 28, 2026 | filing ↗ | |
| BlackRock, Inc. | 6.9% | 13G | Apr 23, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Kiil Harry Skip | $139K | Sep 16, 2026 | filing ↗ |
| Matthew R. Walter | $258K | Jul 8, 2026 | filing ↗ |
| Kiil Harry Skip | $337K | Jun 8, 2026 | filing ↗ |
| Kiil Harry Skip | $5.1M | Feb 19, 2026 | filing ↗ |
| Gregory L. Smith | $3.1M | Nov 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Sep 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 1, 2026 | filing ↗ |
| Earnings (2.02) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Earnings (2.02) | Nov 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 18, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 1, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Oct 16, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 16, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 29, 2025 | filing ↗ |
| Other events (8.01) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |